ReWalk Robotics Ltd., the leading global exoskeleton manufacturer, unveiled today the latest edition of its Personal powered exoskeleton system—the ReWalk Personal 6.0—marking the company's sixth generation community use product.
The ReWalk Personal 6.0 offers those in the spinal cord injured community the most functional exoskeleton system with the fastest walking speed and the most precise fit, among many other key benefits. The ReWalk Personal 6.0 is the latest version of the FDA cleared exoskeleton, which can be used at home and in the community.
"The launch of the 6.0 offers those with spinal cord injury an exoskeleton design that fits better, walks faster and has better gait control than prior generations of the product," said ReWalk's CEO Larry Jasinski. "Our design efforts are built on many years of user experience with a philosophy of offering an outstanding product for use in all aspects of everyday life. The enhanced design of the 6.0 offers highly customized fittings, and software to better match the size and anatomy of each individual user, providing a better walking experience than any prior design and over any other known products in clinical trials around the world."
The ReWalk 6.0 System at a Glance:
The Most Precise Fit: The Personal 6.0 System is fitted to the user's measurements and custom ordered for each individual. This precise fit enhances system function, safety and alignment of the user's joints.
Fastest Walking Speed: Clinical research on the ReWalk device has demonstrated that users can walk at speeds up to 0.71 meters / second, faster than any other exoskeleton.
Streamlined Design: The removal of the backpack eliminates weight from the shoulders, giving the user freedom for clothing choice and movement. The sleek redesign of the strapping and padding provides the users with an easier and faster capacity to put the system on and take it off.
"Our experience and feedback from daily use of the ReWalk systems in the community, combined with technical advances achieved by our R&D organization have enabled this next generation prosthetic exoskeleton," said Jodi Gricci, VP of Global Marketing and Training at ReWalk. "Our user evaluations with the 6.0 demonstrated the value of better fit, improved gait control and more comfort with the removal of the backpack in this streamlined design."
ReWalk remains the only exoskeleton manufacturer in the United States with FDA clearances for both its Personal and Rehabilitation systems. ReWalk has also received regulatory clearances for their systems in several global geographies including: North America, Europe, Asia, the Middle East and Australia. ReWalk is the most used exoskeleton worldwide, with Personal and Rehabilitation Systems in use across several continents.
ReWalk is the most studied exoskeleton in the industry. The wealth of clinical data has provided great insight into the potential health benefits that result from standing and walking using the ReWalk systems. Studies have identified a number of health benefits including: improved bladder and bowel function, improved mental health, improved sleep, reduced fatigue, decreased body fat, decreased pain and improved posture and balance.
The ReWalk Personal 6.0 Systems are now available for purchase, with anticipated delivery of the first units this summer.